Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1994-07-19
1998-03-31
Ketter, James
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
536 245, C12N 522, C07H 2100
Patent
active
057337810
ABSTRACT:
The present invention concerns the use of oligonucleotides to inhibit propagation of human immunodeficiency virus (HIV). Preferred HIV target sites are identified and oligonucleotides designed to hybridize to a target site, or be analogous to a target site, are described. The preferred use of the oligonucleotides is to inhibit HIV propagation in a patient infected with HIV.
REFERENCES:
patent: 4689320 (1987-08-01), Kaji
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5110802 (1992-05-01), Cantin et al.
patent: 5144019 (1992-09-01), Rossi et al.
patent: 5166195 (1992-11-01), Ecker
patent: 5226326 (1993-07-01), Bresser et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5585479 (1996-12-01), Hoke et al.
Agrawal et al. "Oligondeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus" Proc. Natl. Acad. Sci. USA 85: 7079-7083, Oct. 1988.
Ratner et al. Complete Nucleotide Sequence of the AIDS Virus, HTLV-III. Nature 313, 277-284, Jan. 1985.
Helen and Toulme, "Specific Regulation Of Gene Expression by Antisense, Sence and Antigene Nucleic Acids," Chemica et Biophysica Acta 1049:99-125 (1990).
Uhlmann and Peyman, "Antisense Oligonucleotides: A New Therapeutic Principle," Chemical Reviews 90:544-584 (1990).
Majumdar et al., "Stepwise Mechanism of HIV Reverse Transcriptase: Primer Function of Phosphorothioate Oligodeoxynucleotide," Biochemistry 28:1340-1346 (1989).
Matsukura et al., "Regulation of Viral Expression of Human Immunodeficiency Virus In Vitro by an Antisense Phosphorothioate Oligodeoxynucleotide Against rev (art/trs) in Chronically Infected Cells," Proc. Natl. Acad. Sci. USA 86:4244-4248 (1989).
Juliano and Akhtar, "Liposomes as a Drug Delivery System for Antisense Oligonucleotides," Antisense Research and Development 2:165-176 (1992).
Kinchington et al., "A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1," Antiviral Research 17:53-62 (1992).
Rhodes and James, "Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA," Journal of General Virology 71:1965-1974 (1990).
Schwartz et al., "Cloning and Functional Analysis of Multiply Spliced mRNA Species of Human Immuodeficiency Virus Type I," Journal of Virology 64:2519-2529 (1990).
Sullivan et al., "Inhibition of Human Immunodeficiency Virus-1 Proliferation by Liposome-Encapsulated Sense DNA to the 5' TAT Splice Acceptor Site," Antisense Research and Development 2:187-197 (1992).
Vaishnav and Wong-Staal, "The Biochemistry of Aids," Annu. Rev. Biochem. 60:577-630 (1991).
Weislow et al., "New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Nature Products for AIDS-Antiviral Activity," J. Natl. Cancer. Inst. 81:577-586 (1989).
Kwoh Theodore Jesse
Ryder Thomas B.
Gen-Probe Incorporated
Ketter James
Larson Thomas G.
LandOfFree
Oligonucleotides and methods for inhibiting propagation of human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides and methods for inhibiting propagation of human, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides and methods for inhibiting propagation of human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-51210